Bio-Techne Corp. Q2 Profit Increases, Beats Estimates
Bio-Techne Corp. (TECH) announced earnings for its second quarter that increased from last year and beat the Street estimates. The ...
Bio-Techne beats Q2 earnings estimates on improving demand for biotech products
Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...
Bio-Techne reports Q2 adjusted EPS 42c, consensus 38c
Reports Q2 revenue $297.03M, consensus $285.42M. “The Bio-Techne (TECH) team once again executed at a high level and delivered strong second ...
Yahoo Finance28d
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
MINNEAPOLIS, Jan. 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and ...
Yahoo Finance29d
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies ...
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by MassMutual Private Wealth & Trust FSB
MassMutual Private Wealth & Trust FSB raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 60.4% in the fourth quarter, according to its most recent Form 13F filing with the ...